Mobidiag
The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business.
Hologic to Acquire Finnish MDx Firm Mobidiag for Approximately $795M
Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms.
Mobidiag SARS-CoV-2, Influenza A/B, RSV Test Receives CE Mark
The firm said it is currently also developing Novodiag Resp-4, a molecular test for the rapid, on-demand detection of the viruses.
In Brief This Week: Thermo Fisher Scientific, Myriad Genetics, Fulgent Genetics, and More
News items for the in vitro diagnostics industry for the week of June 15, 2020.
Mobidiag Receives CE Mark for Two PCR SARS-CoV-2 Tests
The company already offers an antibody test, Anti-SARS-CoV-2 Rapid Test, that it is distributing for its Chinese joint venture partner Autobio Diagnostics.
Feb 12, 2020
Jan 7, 2020
Mobidiag Garners €1.5M for Sepsis MDx
Jul 1, 2019
Mobidiag Inks African Distribution Agreement
May 14, 2019
Mobidiag Secures €25M Loan to Build Test Menu
May 24, 2018
Mobidiag Concludes €4M Funding Round
Apr 19, 2018
Mobidiag Gets CE Marks for Two Tests
Nov 27, 2017
Interlux to Distribute Mobidiag Products in Estonia
Jun 26, 2017